Varenicline for smoking cessation
167 results
101 - 167
Smoking cessation interventions for smokers with current or past depression: Cochrane systematic review
Varenicline and bupropion and suicidal behaviour 
Cytisine appears to be effective for smoking cessation- Smoking cessation
- Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
- Interventions for preoperative smoking cessation: Cochrane systematic review
- Varenicline increases smokeless tobacco cessation
- Varenicline effective for smokers preferring to "cut down" rather than quit "cold turkey"
- Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses
- Varenicline similar in effectiveness to nicotine patch
- Antidepressants for smoking cessation
- Interventions for waterpipe smoking cessation
- Training health professionals in smoking cessation
- Smoking reduction interventions for smoking cessation
- Inpatient smoking cessation strategy promising, but effects aren't long lasting
- Interventions for smoking cessation in hospitalised patients
- Combo treatment better than varenicline alone in male and highly dependent smokers
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Interventions for smoking cessation in Indigenous populations: Cochrane systematic review
- Relapse prevention interventions for smoking cessation
- Relapse prevention interventions for smoking cessation
- Interventions for tobacco use cessation in people living with HIV
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Interventions to reduce harm from continued tobacco use
- Antidepressants for smoking cessation
- Combined nicotine replacement therapy for smoking cessation
- Nicotine replacement therapy for smoking cessation
- Interventions for smokeless tobacco use cessation
- Cytisine is inexpensive, safe, and modestly effective for smoking cessation
- Interventions for preventing weight gain after smoking cessation
- Varenicline, bupropion may not increase risk of cardiovascular events
- Varenicline (Chantix) not associated with increased CV events
- Nicotine replacement therapy to reduce continued tobacco use
- Postdischarge tobacco cessation intervention results in higher quit rates for hospitalized smokers
- Smoking cessation for people with chronic obstructive pulmonary disease
- Combined pharmacotherapy and behavioural interventions for smoking cessation
- Differences in the effectiveness of individual‐level smoking cessation interventions by socioeconomic status
- Interventions for quitting vaping
- Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
- Interventions for recruiting smokers into cessation programmes
- Interventions for smokeless tobacco use cessation
- Interventions to increase adherence to medications for tobacco dependence
- Nicotine replacement with e-cigarettes might help smokers quit
- Electronic cigarettes for smoking cessation
- ACC/AHA guideline for the management of patients with chronic coronary disease